Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes

Ildiko Lingvay,Nadine Beetz,Regina Sennewald,Annette Schuler-Metz,Julia Bertulis,Christina Loley,Benjamin Lang,Caroline Lippert,Jisoo Lee,Linda Shapiro Manning,Derek Terada

Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes

2020

Ildiko Lingvay
Nadine Beetz
Regina Sennewald
Annette Schuler-Metz
Julia Bertulis
Christina Loley
Benjamin Lang
Caroline Lippert
Jisoo Lee
Linda Shapiro Manning
Derek Terada

Objectives: Fixed-dose combination (FDC) therapy can improve outcomes in type 2 diabetes (T2D). We evaluated the bioequivalence of 2 doses of an FDC of extended-release metformin (metformin XR), em...

Keywords:

Type 2 diabetes
Metformin
Empagliflozin
Pharmacology
Physical therapy
Empagliflozin, Linagliptin
Linagliptin
Medicine
Fixed-dose combination
Diabetes mellitus
Bioequivalence

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations